ArticleCell proliferation2018

Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis.

Shipeng Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.